opioid agonist treatment
Showing 1 - 25 of 5,796
Opioid Use Disorder, Methadone, Cannabis Trial in Vancouver (Aurora 1:1 Drops (Indica), Placebo)
Not yet recruiting
- Opioid Use Disorder
- +3 more
- Aurora 1:1 Drops (Indica)
- Placebo
-
Vancouver, British Columbia, CanadaRapid Access Addiction Clinic (RAAC), St. Paul's Hospital
Aug 3, 2023
Substance-Related Disorders Trial in Stavanger, Bergen (Exercise intervention)
Recruiting
- Substance-Related Disorders
- Exercise intervention
-
Stavanger, Rogaland, Norway
- +1 more
Aug 5, 2022
Opioid Use, Sedative Use Trial in Lexington (Opioid Agonist, Sedatives)
Recruiting
- Opioid Use
- Sedative Use
- Opioid Agonist
- Sedatives
-
Lexington, KentuckyCenter on Drug and Alcohol Research
Nov 17, 2022
Opioid Use, Alcohol Drinking Trial in Lexington (Alcohol, Opioid Agonist)
Recruiting
- Opioid Use
- Alcohol Drinking
- Alcohol
- Opioid Agonist
-
Lexington, KentuckyUniversity of Kentucky
Oct 28, 2022
Substance-Related Disorders Trial in Stavanger, Bergen (Fruit smoothie)
Recruiting
- Substance-Related Disorders
- Fruit smoothie
-
Stavanger, Rogaland, Norway
- +1 more
Aug 5, 2022
Opioid Use Disorder, Chronic Pain Trial in West Haven (Steps 2 Change (S2C), Control)
Recruiting
- Opioid Use Disorder
- Chronic Pain
- Steps 2 Change (S2C)
- Control
-
West Haven, ConnecticutVA Connecticut Healthcare System West Haven Campus, West Haven,
Apr 5, 2022
Smoking Cessation, Substance-Related Disorders Trial in Bergen, Stavanger (drug, behavioral, other)
Recruiting
- Smoking Cessation
- Substance-Related Disorders
- Nicotine patch
- +5 more
-
Bergen, Norway
- +1 more
Aug 8, 2022
Substance Use Disorders Trial in Boston (Distress Tolerance - Benzodiazepine Discontinuation (DT-BD), BZD discontinuation
Completed
- Substance Use Disorders
- Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)
- BZD discontinuation protocol
-
Boston, MassachusettsBoston Medical Center
Jan 20, 2022
Substance Use Disorders Trial in Pittsburgh, Wilkinsburg (Distress Tolerance - Benzodiazepine Discontinuation (DT-BD),
Recruiting
- Substance Use Disorders
- Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)
- Relaxation Therapy
-
Pittsburgh, Pennsylvania
- +2 more
Aug 2, 2022
Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)
Not yet recruiting
- Opioid Use Disorder
- Opioid Withdrawal
- BXCL501 (180 micrograms)
- +3 more
- (no location specified)
Jan 24, 2023
Marijuana Usage, Opioid Use Trial in Lexington (Vaporized Marijuana, Opioid Agonist)
Recruiting
- Marijuana Usage
- Opioid Use
- Vaporized Marijuana
- Opioid Agonist
-
Lexington, KentuckyUniversity of Kentucky
Sep 13, 2021
Opioid-Related Disorders, HIV, HIV Trial in Bronx (Buprenorphine, Methadone)
Completed
- Opioid-Related Disorders
- +2 more
-
Bronx, New York
- +1 more
Jan 28, 2022
Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy Trial in Bergen, Stavanger (Health care delivery)
Active, not recruiting
- Hepatitis C, Chronic
- Opioid Dependence, on Agonist Therapy
- Health care delivery
-
Bergen, Hordaland, Norway
- +1 more
Aug 5, 2022
Sleep Disorder, Healthy Trial in Baltimore (Sleep Fragmentation, Within-Subject test of blinded study medication (stimulant,
Recruiting
- Sleep Disorder
- Healthy
- Sleep Fragmentation
- +3 more
-
Baltimore, MarylandJohns Hopkins School of Medicine
Nov 14, 2022
Healthy Trial in West Haven (Salvinorin A, Placebo)
Completed
- Healthy
- Salvinorin A
- Placebo
-
West Haven, ConnecticutVA Connecticut Healthcare System
Apr 6, 2022
Opioid Use Disorder Trial (Inhaled vaporized cannabis, Intransal opioid)
Not yet recruiting
- Opioid Use Disorder
- Inhaled vaporized cannabis
- Intransal opioid
- (no location specified)
Feb 6, 2023
The Impact of Opioid and Cannabis Exposure on Fetal Growth
Recruiting
- Pregnancy Related
- +3 more
-
Hamilton, Ontario, Canada
- +4 more
Jun 2, 2023
Post Spinal Shivering Trial (Dexmedetomidine injection, Tramadol)
Not yet recruiting
- Post Spinal Shivering
- Dexmedetomidine injection
- Tramadol
- (no location specified)
Nov 14, 2022
Osteoarthritis of the Knee Trial in United States (ARRY-371797, p38 inhibitor; oral, Oxycodone HCl (HCl) extended release (ER),
Completed
- Osteoarthritis of the Knee
- ARRY-371797, p38 inhibitor; oral
- +2 more
-
Phoenix, Arizona
- +12 more
Oct 6, 2020
Opioid-Use Disorder Trial in Baltimore (Placebo, TRV734)
Recruiting
- Opioid-Use Disorder
- Placebo
- TRV734
-
Baltimore, MarylandNational Institute on Drug Abuse
Dec 14, 2022
Moderate to Severe Opioid Use Disorder Trial in Canada (Extended Release Subcutaneous Buprenorphine, Immediate Release
Not yet recruiting
- Moderate to Severe Opioid Use Disorder
- Extended Release Subcutaneous Buprenorphine
- Immediate Release Sublingual Buprenorphine
-
Barrie, Ontario, Canada
- +4 more
Oct 20, 2022
Opioid-Related Disorders, Pain, Chronic Trial in Fall River (hatha yoga, health education)
Completed
- Opioid-Related Disorders
- Pain, Chronic
- hatha yoga
- health education
-
Fall River, MassachusettsStanley Street Treatment and Resources
Aug 8, 2019
Effectiveness and Cost-effectiveness of LADB
Not yet recruiting
- Opioid Dependence
- long-acting depot buprenorphine (LADB)
- (no location specified)
Nov 16, 2023
Opioid Use Disorder, Opioid Use, Opioid Abuse Trial in Boston (buprenorphine/naloxone)
Not yet recruiting
- Opioid Use Disorder
- +4 more
-
Boston, MassachusettsBicycle Health
Nov 30, 2022